Find Academic Supervisors

Lene Kongsgaard Nielsen is an Associate Professor at the University of Southern Denmark (SDU) , affiliated with the Department of Clinical Research and the Research Unit of Haematology (Odense) . Her work focuses on quality of life and symptom management in hematologic malignancies, particularly multiple myeloma and diffuse large B-cell lymphoma . She specializes in patient-reported outcomes and clinical trials for novel therapies. Research Interests include optimizing post-treatment care for myeloma patients, evaluating side effects of emerging therapies (e.g., carfilzomib-related dyspnea), and translating clinical trial data into real-world applications. Her ORCID profile highlights 100+ research outputs with recent focus on BCMA-CD3 bispecific antibodies , belantamab mafodotin , and symptom burden analysis . Scientific Awards Young Investigator Award (Danish Myeloma Study Group, 2019) Student Award Winner (2017) She has served as a peer reviewer for The Lancet Haematology , American Journal of Hematology , and European Journal of Haematology . Her teaching includes courses on Patient-Reported Outcomes and cancer symptom management .

• Quality of Life
• Multiple Myeloma
• Patient-Reported Outcome
• +3 more

Professor Thomas Levin Geiser Andersen is a distinguished academic and researcher at the University of Southern Denmark, where he serves as Professor and Group Leader of Molecular Bone Histology at the Clinical Institute and Research Unit for Pathology in Odense. His work is closely associated with DanSIC (Danish National Biobank) and Odense University Hospital (OUH), where he maintains a strong clinical research presence. Professor Andersen's research primarily focuses on bone biology, with particular expertise in osteoclast and osteoblast function, bone remodeling processes, and the pathological mechanisms underlying bone diseases. His fingerprint analysis reveals significant contributions to understanding Osteoclast (100%), Osteoblast (91%), Osteolysis (84%), Ossification (78%), and Bone Remodeling (77%) processes, with clinical applications in Osteopathy (48%) and Multiple Myeloma (47%). His work bridges basic science with clinical applications, particularly in how bone diseases manifest in conditions like multiple myeloma. His recent publications demonstrate a strong trend toward understanding the molecular mechanisms of bone diseases, with particular emphasis on the interaction between cancer cells (especially multiple myeloma) and bone tissue. His research spans from fundamental cellular processes to clinical applications, with growing interest in therapeutic interventions for bone-related pathologies. The interdisciplinary nature of his work is evident in collaborations spanning hematology, endocrinology, and ophthalmology. Collaborative Research travel grant, The Burroughs Wellcome Fund, US (2017) The Aase and Ejnar Danielsen Foundation award (2016) EU grant (2016) Region of Southern Denmark Research Fund (2014, 2011) Professor Andersen has been actively involved in PhD supervision and teaching, with documented guidance on projects related to intracortical bone remodeling, osteoprogenitor cells, and aging bone. His leadership extends to organizing research workshops, including the 1st Bone Research Workshop at Sandbjerg Estate in 2018. He serves as an internal examiner and participates in assessment committees, demonstrating his commitment to academic development. His research group focuses on molecular bone histology, with particular expertise in bone remodeling events and their clinical implications.

• Bone Biology
• Osteoclasts
• Osteoblasts
• +5 more

Stine Krogh Venø is an Associate Professor and Doctor at Aalborg University Hospital, affiliated with the Clinical Institute of the Faculty of Health Sciences in the Cardiology Department. She maintains a dual role as both an academic researcher and clinical practitioner, contributing significantly to cardiovascular medicine and clinical biochemistry with a focus on atrial fibrillation and stroke prevention. Her research interests span several key areas in cardiology, with particular emphasis on atrial fibrillation management, stroke prevention strategies, and the therapeutic role of omega-3 fatty acids in cardiovascular health. Dr. Venø's work bridges clinical practice and laboratory research, addressing both diagnostic challenges in clinical biochemistry and therapeutic interventions in cardiovascular disease. Her research demonstrates a strong commitment to improving patient outcomes through evidence-based practice and innovative diagnostic approaches. Dr. Venø's publication record shows a consistent trajectory of impactful research, with recent work focusing on optimal medical therapy for heart failure in atrial fibrillation patients, preanalytical stability of blood analytes, and the relationship between omega-3 fatty acids and stroke risk. Her research demonstrates methodological diversity, employing population-based studies, clinical trials, and diagnostic evaluations to address critical questions in cardiovascular medicine. Her scientific contributions have established her as a respected researcher in cardiovascular medicine, with collaborations spanning multiple institutions and countries as evidenced by her extensive publication record and research network. Dr. Venø actively participates in large-scale international studies such as the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry, contributing to the development of evidence-based guidelines in cardiovascular care. As both a clinician and researcher, Dr. Venø maintains a strong connection between laboratory science and patient care, ensuring that her research has direct clinical relevance and application. Her work on preanalytical factors in laboratory testing demonstrates her commitment to improving diagnostic accuracy and reliability in clinical practice.

• Cardiology
• Atrial Fibrillation
• Stroke Research
• +5 more

Thomas Levin Andersen is a Professor in the Department of Clinical Research at the University of Southern Denmark, with additional appointment as Associate Professor at KI, OUH, Research unit of Pathology in Odense. His academic career spans bone biology, pathology, and clinical research with a particular focus on bone remodeling processes. Dr. Andersen's research interests center around bone biology with specific expertise in osteoclast and osteoblast function, bone remodeling processes, multiple myeloma-related bone disease, and osteoporosis. His work bridges basic science with clinical applications, particularly in understanding the cellular mechanisms underlying bone diseases and developing potential therapeutic approaches. Analysis of his recent publications reveals a strong focus on bone remodeling mechanisms, particularly intracortical remodeling, with increasing attention to the intersection of bone biology with other systems including adipose tissue metabolism and multiple myeloma. His research employs diverse methodologies from in vitro cell culture to animal models and human clinical studies. Collaborative Research travel grant, The Burroughs Wellcome Fund, US (2017) Aase og Ejnar Danielsen Fonden (2016) EU grant (2016) Region Syddanmarks Forskningspulje (2014) Region of Southern Denmark Research Foundation - 440,000 kr (2011) Dr. Andersen has supervised numerous students and research projects, with particular emphasis on understanding intracortical bone remodeling events, osteoprogenitor cell populations, and the relationship between bone biology and other physiological systems. His research has been supported by multiple grants from national and international funding bodies. He has organized significant academic events including the 1st Bone Research Workshop at Sandbjerg Estate in 2018. His work connects closely with clinical applications, as evidenced by media coverage of his research on bone health and diagnostics, including interviews where he has shared expertise on training for stronger bones and improving diagnostic bone biopsy techniques.

• Bone Remodeling
• Osteoclast Biology
• Osteoblast Biology
• +5 more

Cecilie Velsø Mæng serves as a Guest Researcher in the Grønbæk Group at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen, under the Faculty of Health and Medical Sciences. Her work focuses on clinical hematology with direct implications for diagnostic protocols in plasma cell disorders. Her research specializes in biomarker optimization for monoclonal gammopathy of undetermined significance (MGUS), particularly examining free light chain reference intervals to improve risk assessment models and prevent clinical overdiagnosis. This translational work bridges laboratory medicine and patient care through evidence-based diagnostic refinement. Current research trends indicate strong emphasis on diagnostic precision in pre-malignant hematological conditions, with her 2025 publication establishing revised clinical thresholds that enhance stratification accuracy while reducing unnecessary interventions. Collaborative patterns show international engagement with Danish and Icelandic institutions. She operates within BRIC's research infrastructure at Ole Maaløes Vej 5, Copenhagen, contributing to the Grønbæk Group's mission in cancer biology and therapeutic development through specialized laboratory investigations.

• Hematology
• Oncology
• Clinical Medicine
• +3 more

Alastair Hansen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Pathology. His academic work is based at Herlev Hospital (Borgmester Ib Juuls Vej 1, 2730 Herlev), where he maintains an active research profile with numerous publications in clinical medicine. Dr. Hansen's research primarily focuses on nephrology and immunology, with significant contributions to understanding glomerulonephritis, hypertensive disorders of the kidney, immunodeficiency conditions, and their relationship to various cancers. His work often bridges clinical practice with laboratory research, particularly in the areas of renal pathology and immune responses to infections. He has conducted important research on the interplay between kidney disease and other systemic conditions, including cancer and bone disorders. His publication record shows consistent output with a focus on clinical research articles in high-impact journals. The research trends demonstrate a strong emphasis on observational and case-based studies that address important clinical questions in nephrology and immunology. His work often involves large cohort studies and national registry analyses, particularly evident in his 30-year glomerulonephritis study. Dr. Hansen has collaborated extensively with researchers across multiple Danish institutions, particularly within the Capital Region of Denmark. His work shows strong connections between clinical practice at Herlev Hospital and academic research at the University of Copenhagen. He has been involved in studies examining the intersection of immunology and kidney disease, particularly during the early phases of the SARS-CoV-2 pandemic.

• Nephrology
• Immunology
• Pathology
• +5 more

Abbas Jafari Kermani serves as an Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. He leads the Morphogenesis and Differentiation Program within the Institute of Cellular and Molecular Medicine (ICMM), focusing on skeletal stem cell biology and bone metabolism research. His research interests center on understanding the mechanisms regulating skeletal stem cell differentiation into osteoblasts and adipocytes, with particular focus on how these processes contribute to bone loss in inflammatory conditions, cancer, and aging. Key research areas include the regulatory mechanisms of mesenchymal stem cell (MSC) fate specification, the role of lysosomal proteases (especially legumain) in bone and systemic energy homeostasis, MSC-secreted factors in bone pathology, and bone marrow adipose tissue function in skeletal health. Analysis of his recent publications (2023-2025) reveals a strong interdisciplinary approach connecting bone biology with metabolism and cancer research. His work demonstrates significant interest in the molecular mechanisms underlying bone loss pathologies and the crosstalk between bone, fat, and muscle tissues. Multiple publications highlight the role of legumain protease in vitamin D metabolism, glucose regulation, and bone formation processes. Dr. Jafari Kermani's teaching activities span multiple academic levels including medical students, bachelor's, master's, and PhD programs. His research group also provides research training for postdoctoral fellows and international researchers, contributing to the development of next-generation scientists in bone and stem cell biology. His research has gained notable attention with publications being picked up by news outlets, discussed on social media platforms including X (formerly Twitter), mentioned on Facebook pages, Reddit, and featured in videos. His work has been cited by numerous researchers as evidenced by Mendeley readership metrics across his publications.

• Mesenchymal Stem Cell Biology
• Bone Biology
• Osteoporosis Research
• +5 more